SANA KHURRAM

Prof. Dr. SANA KHURRAM


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2024 in Human Nature Journal of Social Sciences
Verified
Journal Article
Open access
PDF file
FRFouzia Rehman
Fouzia Rehman
MOMuniza Omair
Muniza Omair
NZNida Zeeshan
Nida Zeeshan
SKSANA KHURRAM
SANA KHURRAM
Aim of the Study: Artificial Intelligence (AI) assimilation into the field of medicine has the potential to considerably increase the accuracy, efficiency, and overall quality of patient care. Methodology: This cross-sectional mixed method study (QUAN-qual) investigates the attitudes, knowledge, and practices concerning AI among healthcare professionals and its impact on their clinical opinions and decision-making. For this purpose, (n=146) healthcare professionals were selected through stratified random sampling. Findings: The study findings reveal that the majority of healthcare professionals hold a positive attitude toward the utilization of AI in healthcare. A significant portion lacks adequate awareness of AI tools and related applications, though the utilization of AI is moderately prevalent in clinical practices. The majority of healthcare professionals admitted that AI has many benefits in the healthcare field from improving diagnostic accuracy, observing patient’s progress, and handling treatment plans. Nonetheless, they also stressed considerable challenges including lack of expertise in accessing technical equipment, ethical-concerns, and data privacy, with a major fear of their own job displacement. Furthermore, study found a significant positive correlation between attitude, knowledge, and practices of AI among healthcare professionals. Conclusion: There is still a need for targeted training programs and improvement in policies that can support professionals to understand AI and its utilization in their field. A significant collaboration is required among technologists, healthcare providers, and ethicists to develop and implement AI solutions. However, its successful implementation depends on overcoming significant challenges in the medical field related to knowledge, attitude, and ethical concerns.

29 March 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HAHassan Ahmad
Hassan Ahmad
FHFathimathul Henna
Fathimathul Henna
SKSANA KHURRAM
SANA KHURRAM
AKAyesha Khan
Ayesha Khan
AAAlisha Ahmed
Alisha Ahmed
AAashfaq Ahmad
ashfaq Ahmad
Acute promyelocytic leukemia (APL) is an aggressive malignancy. Although recent advancements in therapy have improved outcomes, differing toxicity profiles

18 August 2026 in Considerations in Medicine
Verified
Journal Article
Open access
PDF file
SKSANA KHURRAM
SANA KHURRAM
Randomised controlled trials remain essential for establishing treatment efficacy in haematology, but they cannot fully represent the diversity of patients, care pathways, and resource constraints encountered in routine practice, particularly in low- and middle-income countries (LMICs). This commentary argues for an integrated evidence system that combines locally generated real-world data with fit-for-purpose evidence-synthesis methods to advance precision haematology. Routinely collected clinical, laboratory, treatment, toxicity, and outcome data can clarify real-world effectiveness, long-term safety, uncommon adverse events, and variations in access to care. However, credible real-world evidence requires standardised datasets, clearly defined causal questions, appropriate handling of confounding and missing data, transparent reporting, and robust governance. Different synthesis methods should be matched to specific questions: individual participant data meta-analysis can examine treatment-effect heterogeneity; network meta-analysis can compare multiple interventions; living systematic reviews can maintain evidence currency; and realist and meta-narrative reviews can explore context and implementation. Machine-learning and federated approaches may further strengthen evidence generation, but only after data quality, interoperability, validation, and clinical relevance have been established. Progress in LMICs will require sustained investment in registries, data managers, biostatisticians, secure infrastructure, and equitable international collaboration. Connecting trial evidence, real-world evidence, and appropriate evidence synthesis rather than treating them as competing approaches could make precision haematology more context-responsive, implementable, and equitable.

5 July 2026 in Scientific Reports
Verified
Journal Article
Open access
ZAZaen Al Abideen
Zaen Al Abideen
SKSANA KHURRAM
SANA KHURRAM
AKAlmas Khan
Almas Khan
KSKashif Hafeez Shaikh
Kashif Hafeez Shaikh
MOMuniza Omair
Muniza Omair
SKSehrish Khurshid
Sehrish Khurshid
Β-thalassemia trait (β-TT) is a common hemoglobin disorder that is frequently confused with iron deficiency anemia (IDA), leading potentially low-yield confirmatory hemoglobin fraction analysis and increased use of healthcare resources. To assess the appropriateness of β-TT screening in patients with microcytic hypochromic anemia and to detect laboratory and clinical predictors of potentially low yield testing. A total of 12,622 patients with microcytic hypochromic anemia who underwent hemoglobin fraction analysis by HPLC between February 2023 to July 2025 were included in this retrospective cross-sectional study. Data on complete blood counts, Pathologist remarks, and HPLC results were collected. Red cell indices (Mentzer Index) , HbA₂ levels, and recorded clinical context were used to operationally classify testing appropriateness. Multivariable multinomial logistic regression was used to identify predictors of test appropriateness. Among the 12,622 patients, 3932 (31.2%) had confirmed β-TT, 8312 (65.9%) had non-β-TT microcytic anemia, and 378 (3.0%) had borderline HbA₂ values. Testing was categorized as appropriate in 2544 cases (20.2%), potentially low-yield in 5678 cases (45.0%), and unclear in 4400 cases (34.9%) based on red cell indices, HbA 2 levels, and clinical context. While suspected β-TT significantly predicted appropriate testing, suspected IDA (OR 4.00, p < 0.001), female sex (OR 1.50, p < 0.001), and post-transfusion samples (OR 4.27, p < 0.001) were independently associated with potentially low-yield testing. The possible masking effect of iron deficiency on β-TT detection was reflected by the fact that 490 patients (3.9%) were recommended to undergo a repeat HPLC after iron supplementation to rule out iron deficiency-mediated suppression of HbA₂ as a potential masking factor for β-TT. A significant portion of β-TT screening my be potentially low-yield, which may affect clinical results and available resources. Test utilization may be optimized and diagnostic accuracy may be improved by evaluating iron status, repeating testing after iron correction when indicated and interpreting red cell indices in appropriate clinical setting.

27 May 2026 in ecancermedicalscience
Verified
Journal Article
Open access
SKSANA KHURRAM
SANA KHURRAM
ABAli Abdul Basit
Ali Abdul Basit
MQMuhammad Asif Qureshi
Muhammad Asif Qureshi
Acute myeloid leukaemia (AML) is a genetically diverse malignancy with a high incidence in Pakistan. But patients rarely benefit from personalized care due to the unavailability of molecular diagnostics. This study aims to identify actionable genetic variants in adult Pakistani AML patients by using the inDxTM Extended AML/myelodysplastic syndrome panel for targeted next generation sequencing (NGS). Nine patients were included (median age = 42 years, 77.8% males). Mutations were found in six (66.7%) patients. The total number of mutations was 13 and these mutated 11 different genes, nine genes being affected in single cases (7.7%) and two genes: WT1 and DNMT3A, were mutated in two cases (15.4% each). Missense mutations constituted 69.2% of all 13 mutations. The variant allele frequencies for these mutations ranged from 7% to 54%. A number of clinically important mutations were observed, including an adverse WT1 variant, a favourable NPM1 mutation, targetable IDH1/JAK2 dual mutations and a myelodysplasia-related U2AF1 mutation. Co-mutation of DNMT3A with KRAS/NRAS or NPM1 indicated complex clonal dynamics. One of the three patients with no detectable mutations on NGS, was found Breakpoint cluster region-abelson murine leukaemia viral oncogene homolog 1-positive through polymerase chain reaction. This highlights the limitations of NGS panel, and advocates for the need for a multi-layered diagnostic approach. These findings support the viability of NGS in detecting clinically significant mutations in low-resource settings to guide risk stratification and personalized treatment planning. This study highlights the need for broader NGS integration in routine care and larger regional studies to improve AML management in Pakistan.

4 August 2026 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
MOMuniza Omair
Muniza Omair
SKSANA KHURRAM
SANA KHURRAM
ANAyesha Nadeem
Ayesha Nadeem
LSLaibah Salman
Laibah Salman
MRMaryam Raza
Maryam Raza
FMFarzeen Manzar
Farzeen Manzar
Objective: To assess dental maturity and overall dental health status in children with β-thalassemia major (β-TM) compared with healthy controls, and to examine their associations with selected clinical, anthropometric, and laboratory parameters. Methods: A hospital-based observational case-control study was conducted at Dow International Dental College (DIDC), Dow University of Health Sciences (DUHS), between March 10, 2025, and August 5, 2025. Fifty children with β-TM and fifty healthy controls aged 5–16 years were recruited using purposive sampling. Dental maturity was assessed using Nolla’s method via orthopantomograms. Periodontal and dental health was assessed using simplified periodontal screening score, the Silness–Löe Plaque Index, and tooth mobility, which were subsequently combined to generate an overall dental health grade. Data on transfusion frequency, serum ferritin, hemoglobin, and body mass index (BMI) were recorded. Analysis was performed in R software using bivariate tests, multivariable regression models adjusted for age, sex, and BMI, and age-restricted sensitivity analysis. Results: Delayed dental maturity was observed in 56% of children with β-TM and 30% of controls. Children with β-TM showed a higher simplified periodontal screening score and plaque scores than healthy controls. A poor overall dental health grade was observed in 32% of children with β-TM and 6% of healthy controls. In adjusted models, β-TM status was associated with delayed dental maturity (OR = 2.80, 95% CI 1.03–7.91, p = 0.046) and poorer overall dental health grade (OR = 3.17, 95% CI 1.22–8.25, p = 0.018). Within the β-TM group, BMI was associated with delayed dental maturity (OR = 1.12, 95% CI 1.03–1.26, p = 0.025). Male sex was associated with lower odds of poorer overall dental health grade (OR = 0.23, 95% CI 0.07–0.71, p = 0.011), while transfusion frequency was not significantly associated with dental maturity or overall dental health grade in bivariate analyses. Conclusion: Children with β-TM showed a higher frequency of delayed dental maturity and poorer overall dental health grade compared with healthy controls. BMI was associated with delayed dental maturity, whereas transfusion frequency showed no independent effect. These findings highlight the need for longitudinal studies with age-matched controls, validated dental health assessment tools, and more detailed evaluation of nutritional status, oral hygiene practices, socioeconomic factors and inflammatory markers.